---
title: "HealthLynked Corp. | 10-Q: FY2025 Q2 Revenue: USD 592.36 K"
type: "news"
locale: "en"
url: "https://longbridge.com/en/news/253097795.md"
published_at: "2025-08-14T20:19:21.000Z"
---

# HealthLynked Corp. | 10-Q: FY2025 Q2 Revenue: USD 592.36 K

Revenue: As of FY2025 Q2, the actual value is USD 592.36 K.

EPS: As of FY2025 Q2, the actual value is USD 0.

### Health Services Segment

-   **Revenue**: Patient service revenue was $572,840 for the three months ended June 30, 2025, and $1,324,855 for the six months ended June 30, 2025.
-   **Operating Expenses**: Practice salaries and benefits were $285,379 for the three months ended June 30, 2025, and $687,745 for the six months ended June 30, 2025.
-   **Loss from Operations**: Loss from operations was $14,002 for the three months ended June 30, 2025, and $22,825 for the six months ended June 30, 2025.

### Digital Healthcare Segment

-   **Revenue**: Subscription revenue was $7,099 for the three months ended June 30, 2025, and $16,683 for the six months ended June 30, 2025.
-   **Operating Expenses**: Selling, general and administrative expenses were $436,503 for the three months ended June 30, 2025, and $1,057,044 for the six months ended June 30, 2025.
-   **Loss from Operations**: Loss from operations was - $430,578 for the three months ended June 30, 2025, and - $1,042,709 for the six months ended June 30, 2025.

### Medical Distribution Segment

-   **Revenue**: Product revenue was $12,421 for the three months ended June 30, 2025, and $25,030 for the six months ended June 30, 2025.
-   **Operating Expenses**: Cost of product revenue was $15,978 for the three months ended June 30, 2025, and $33,794 for the six months ended June 30, 2025.
-   **Loss from Operations**: Loss from operations was - $18,809 for the three months ended June 30, 2025, and - $32,890 for the six months ended June 30, 2025.

### Cash Flow

-   **Operating Cash Flow**: Net cash used in operating activities was - $850,089 for the six months ended June 30, 2025.
-   **Financing Activities**: Net cash provided by financing activities was $794,049 for the six months ended June 30, 2025.

### Future Outlook and Strategy

-   **Core Business Focus**: The company plans to profitably operate its Health Services business and continue investing in its Digital Healthcare business, including the HealthLynked Network.
-   **Funding Requirements**: The company plans to raise additional capital to fund its ongoing operations and marketing efforts for the HealthLynked Network.

### Related Stocks

- [HLYK.US - HealthLynked Corp.](https://longbridge.com/en/quote/HLYK.US.md)
- [HLYKD.US - HEALTHLYNKED CORP](https://longbridge.com/en/quote/HLYKD.US.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| Healthlynked 向由首席执行官控制的信托发行了 570 万美元的可转换票据 | Healthlynked Corporation 向由首席执行官 Michael Dent 博士控制的 Mary S. Dent Gifting Trust 发行了一份 570 万美元的高级担保可转换票据。该票据于 2029 年 2 月 2 | [Link](https://longbridge.com/en/news/275171792.md) |

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.